Dengue Testing Market Size, Share & Trends Analysis Report By Product (ELISA-based Tests, Dengue IgG/IgM Detection Kits, RT-PCR Tests, Rapid Diagnostic Tests), By Service Type, By End-use (Home Healthcare, Clinical Labs), By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Dengue Testing Market Growth & Trends
The global dengue testing market size is expected to reach USD 822.61 million by 2030, registering a CAGR of 5.22% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as urbanization, climate change, and increased international travel have expanded the habitats of Aedes mosquitoes, the primary vectors for dengue transmission. For instance, in 2023, India reported nearly 300,000 dengue cases, highlighting the disease's growing prevalence in Asia-Pacific region. This escalating incidence necessitates the development and deployment of efficient diagnostic tools to enable early detection and prompt treatment, thereby reducing morbidity and mortality associated with the disease.
Innovations in diagnostic technologies have significantly improved the accuracy and speed of dengue detection. The introduction of advanced methods such as enzyme-linked immunosorbent assays (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and rapid antigen tests has revolutionized the field. These technologies offer high sensitivity and specificity, enabling healthcare providers to diagnose dengue infections promptly. Moreover, the development of point-of-care testing devices facilitates on-site diagnostics, crucial in remote or resource-limited settings. Such advancements not only enhance patient outcomes but also contribute to controlling the spread of the disease.
Governmental and international efforts play a pivotal role in bolstering the dengue testing market. In August 2024, the United States Agency for International Development (USAID) donated dengue and other arbovirus test kits, valued at USD 20,000, to the Caribbean Public Health Agency (CARPHA) to enhance regional outbreak response. Such initiatives underscore the commitment to strengthening diagnostic capacities in vulnerable regions. Additionally, regulatory bodies like the U.S. Food and Drug Administration (FDA) have expedited the approval of innovative diagnostic solutions, such as bioM?rieux's BIOFIRE FILMARRAY Tropical Fever Panel, which received Special 510(k) clearance in December 2024. These concerted efforts facilitate the availability and adoption of advanced diagnostic tools globally.
Heightened awareness about dengue fever and its implications has led to increased demand for diagnostic testing. Public health campaigns and educational programs have been instrumental in informing communities about the symptoms, transmission, and prevention of dengue. This awareness encourages individuals to seek timely medical attention, thereby necessitating efficient diagnostic services. Furthermore, informed communities are more likely to participate in vector control initiatives, indirectly contributing to disease management. The emphasis on education and awareness thus plays a critical role in driving the diagnostics market.
The development and availability of rapid diagnostic test (RDT) kits have transformed dengue detection, especially in endemic regions. These kits offer quick results, often within minutes, facilitating immediate clinical decisions. In August 2023, Fujifilm launched its revolutionary Dengue NS1Ag Test Kit, utilizing proprietary silver amplification technology to enable early diagnosis. Such innovations are crucial in mitigating disease severity and reducing mortality rates. The convenience, affordability, and efficiency of RDTs make them indispensable tools in the global fight against dengue, thereby propelling market growth.
Dengue Testing Market Report Highlights
Thermo Fisher Scientific Inc.
Abbott
F. Hoffmann?La?Roche Ltd.
InBios International, Inc.
NovaTec Immundiagnostica GmbH
Abnova Corporation
PerkinElmer Inc. (Euroimmun AG)
Certest Biotec
DiaSorin S.p.A.
Quest Diagnostics Incorporated
Dengue Testing Market Growth & Trends
The global dengue testing market size is expected to reach USD 822.61 million by 2030, registering a CAGR of 5.22% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as urbanization, climate change, and increased international travel have expanded the habitats of Aedes mosquitoes, the primary vectors for dengue transmission. For instance, in 2023, India reported nearly 300,000 dengue cases, highlighting the disease's growing prevalence in Asia-Pacific region. This escalating incidence necessitates the development and deployment of efficient diagnostic tools to enable early detection and prompt treatment, thereby reducing morbidity and mortality associated with the disease.
Innovations in diagnostic technologies have significantly improved the accuracy and speed of dengue detection. The introduction of advanced methods such as enzyme-linked immunosorbent assays (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and rapid antigen tests has revolutionized the field. These technologies offer high sensitivity and specificity, enabling healthcare providers to diagnose dengue infections promptly. Moreover, the development of point-of-care testing devices facilitates on-site diagnostics, crucial in remote or resource-limited settings. Such advancements not only enhance patient outcomes but also contribute to controlling the spread of the disease.
Governmental and international efforts play a pivotal role in bolstering the dengue testing market. In August 2024, the United States Agency for International Development (USAID) donated dengue and other arbovirus test kits, valued at USD 20,000, to the Caribbean Public Health Agency (CARPHA) to enhance regional outbreak response. Such initiatives underscore the commitment to strengthening diagnostic capacities in vulnerable regions. Additionally, regulatory bodies like the U.S. Food and Drug Administration (FDA) have expedited the approval of innovative diagnostic solutions, such as bioM?rieux's BIOFIRE FILMARRAY Tropical Fever Panel, which received Special 510(k) clearance in December 2024. These concerted efforts facilitate the availability and adoption of advanced diagnostic tools globally.
Heightened awareness about dengue fever and its implications has led to increased demand for diagnostic testing. Public health campaigns and educational programs have been instrumental in informing communities about the symptoms, transmission, and prevention of dengue. This awareness encourages individuals to seek timely medical attention, thereby necessitating efficient diagnostic services. Furthermore, informed communities are more likely to participate in vector control initiatives, indirectly contributing to disease management. The emphasis on education and awareness thus plays a critical role in driving the diagnostics market.
The development and availability of rapid diagnostic test (RDT) kits have transformed dengue detection, especially in endemic regions. These kits offer quick results, often within minutes, facilitating immediate clinical decisions. In August 2023, Fujifilm launched its revolutionary Dengue NS1Ag Test Kit, utilizing proprietary silver amplification technology to enable early diagnosis. Such innovations are crucial in mitigating disease severity and reducing mortality rates. The convenience, affordability, and efficiency of RDTs make them indispensable tools in the global fight against dengue, thereby propelling market growth.
Dengue Testing Market Report Highlights
- Based on product, the ELISA-based tests segment accounted for the largest market share of 44.94% in 2024, driven by their high sensitivity, specificity, and ability to detect both dengue antigens (NS1) and antibodies (IgM and IgG).
- Based on service type, the centralized service segment led the market with a 59.93% revenue share in 2024, driven by the increasing demand for accurate and comprehensive testing solutions. Centralized laboratories, primarily located in hospitals and diagnostic centers, offer advanced diagnostic capabilities, including ELISA and RT-PCR tests, which are essential for confirming dengue infections
- Based on end use, the clinical labs segment dominated the market with a revenue share of 44.16% in 2024. Growth is driven by increased investments in laboratory automation, high?throughput ELISA, and RT?PCR platforms, enabling same?day turnaround.
- In 2024, Asia Pacific led the global market with a share of 31.57%, owing to endemic dengue transmission in India, Indonesia, and Thailand. National vector control programs (e.g., India’s NVBDCP) fund ELISA and RT?PCR in regional labs, while community health centers deploy POC NS1 rapid tests.
Thermo Fisher Scientific Inc.
Abbott
F. Hoffmann?La?Roche Ltd.
InBios International, Inc.
NovaTec Immundiagnostica GmbH
Abnova Corporation
PerkinElmer Inc. (Euroimmun AG)
Certest Biotec
DiaSorin S.p.A.
Quest Diagnostics Incorporated
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Service Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Service Type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. DENGUE TESTING MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising Incidence of Dengue
3.4.2. Technological Advancements
3.4.3. Government and International Initiatives
3.5. Market Restraint Analysis
3.5.1. High Cost of Diagnostic Tests
3.5.2. Limited Access to Healthcare Infrastructure
3.5.3. Porter’s Five Forces Analysis
3.5.4. PESTEL Analysis
CHAPTER 4. DENGUE TESTING MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Dengue Testing Market: Product Movement Analysis
4.2. Dengue Testing Market Estimates and Forecast, by Product
4.3. ELISA-based Tests
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Dengue IgG/IgM Detection Kits
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. RT-PCR Tests
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Rapid Diagnostic Tests (RDTs)
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. NS1 Antigen Detection Kits
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Lateral Flow Immunoassay
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. DENGUE TESTING MARKET: SERVICE TYPE ESTIMATES & TREND ANALYSIS
5.1. Dengue Testing Market: Service Type Movement Analysis
5.2. Dengue Testing Market Estimates and Forecast, by Service Type
5.3. Centralized Service
5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4. POC Service
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. DENGUE TESTING MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Dengue Testing Market: Distribution Movement Analysis
6.2. Dengue Testing Market Estimates and Forecast, by End Use
6.3. Clinical Labs
6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Hospitals /Clinics
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Home Healthcare
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. DENGUE TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Dengue Testing Market Share By Region, 2024 & 2030
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Regional Market Dashboard
7.4. Global Regional Market Snapshot
7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. North America Dengue Testing Market, 2018 - 2030 (USD Million)
7.6.2. U.S.
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
7.6.3. Canada
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Canada Dengue Testing Market, 2018 - 2030 (USD Million)
7.6.4. Mexico
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
7.7. Europe
7.7.1. Europe Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.2. UK
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. UK Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.3. Germany
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Germany Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.4. France
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. France Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.5. Italy
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Italy Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.6. Spain
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Spain Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.7. Denmark
7.7.7.1. Key Country Dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory Framework
7.7.7.4. Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.8. Sweden
7.7.8.1. Key Country Dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory Framework
7.7.8.4. Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.9. Norway
7.7.9.1. Key Country Dynamics
7.7.9.2. Competitive Scenario
7.7.9.3. Regulatory Framework
7.7.9.4. Norway Dengue Testing Market, 2018 - 2030 (USD Million)
7.8. Asia Pacific
7.8.1. Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.2. Japan
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Japan Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.3. China
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. China Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.4. India
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. India Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.5. Australia
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Australia Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.6. Thailand
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory Framework
7.8.6.4. Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.7. South Korea
7.8.7.1. Key Country Dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Regulatory Framework
7.8.7.4. South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
7.9. Latin America
7.9.1. Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
7.9.2. Brazil
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
7.9.3. Argentina
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
7.10. MEA
7.10.1. MEA Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.2. South Africa
7.10.2.1. Key Country Dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory Framework
7.10.2.4. South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.3. Saudi Arabia
7.10.3.1. Key Country Dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory Framework
7.10.3.4. Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.4. UAE
7.10.4.1. Key Country Dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory Framework
7.10.4.4. UAE Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.5. Kuwait
7.10.5.1. Key Country Dynamics
7.10.5.2. Competitive Scenario
7.10.5.3. Regulatory Framework
7.10.5.4. Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Strategy Mapping
8.4. Company Market Share Analysis, 2024
8.5. Company Profiles
8.5.1. Thermo Fisher Scientific Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Abbott
8.5.2.1. Overview
8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. F. Hoffmann?La?Roche Ltd.
8.5.3.1. Overview
8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. InBios International, Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. NovaTec Immundiagnostica GmbH
8.5.5.1. Overview
8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Abnova Corporation
8.5.6.1. Overview
8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. PerkinElmer Inc. (Euroimmun AG)
8.5.7.1. Overview
8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Certest Biotec
8.5.8.1. Overview
8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. DiaSorin S.p.A.
8.5.9.1. Overview
8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Quest Diagnostics Incorporated
8.5.10.1. Overview
8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Service Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Service Type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. DENGUE TESTING MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising Incidence of Dengue
3.4.2. Technological Advancements
3.4.3. Government and International Initiatives
3.5. Market Restraint Analysis
3.5.1. High Cost of Diagnostic Tests
3.5.2. Limited Access to Healthcare Infrastructure
3.5.3. Porter’s Five Forces Analysis
3.5.4. PESTEL Analysis
CHAPTER 4. DENGUE TESTING MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Dengue Testing Market: Product Movement Analysis
4.2. Dengue Testing Market Estimates and Forecast, by Product
4.3. ELISA-based Tests
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Dengue IgG/IgM Detection Kits
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. RT-PCR Tests
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Rapid Diagnostic Tests (RDTs)
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. NS1 Antigen Detection Kits
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Lateral Flow Immunoassay
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. DENGUE TESTING MARKET: SERVICE TYPE ESTIMATES & TREND ANALYSIS
5.1. Dengue Testing Market: Service Type Movement Analysis
5.2. Dengue Testing Market Estimates and Forecast, by Service Type
5.3. Centralized Service
5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4. POC Service
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. DENGUE TESTING MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Dengue Testing Market: Distribution Movement Analysis
6.2. Dengue Testing Market Estimates and Forecast, by End Use
6.3. Clinical Labs
6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Hospitals /Clinics
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Home Healthcare
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. DENGUE TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Dengue Testing Market Share By Region, 2024 & 2030
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Regional Market Dashboard
7.4. Global Regional Market Snapshot
7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. North America Dengue Testing Market, 2018 - 2030 (USD Million)
7.6.2. U.S.
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
7.6.3. Canada
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Canada Dengue Testing Market, 2018 - 2030 (USD Million)
7.6.4. Mexico
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
7.7. Europe
7.7.1. Europe Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.2. UK
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. UK Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.3. Germany
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Germany Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.4. France
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. France Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.5. Italy
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Italy Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.6. Spain
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Spain Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.7. Denmark
7.7.7.1. Key Country Dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory Framework
7.7.7.4. Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.8. Sweden
7.7.8.1. Key Country Dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory Framework
7.7.8.4. Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
7.7.9. Norway
7.7.9.1. Key Country Dynamics
7.7.9.2. Competitive Scenario
7.7.9.3. Regulatory Framework
7.7.9.4. Norway Dengue Testing Market, 2018 - 2030 (USD Million)
7.8. Asia Pacific
7.8.1. Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.2. Japan
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Japan Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.3. China
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. China Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.4. India
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. India Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.5. Australia
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Australia Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.6. Thailand
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory Framework
7.8.6.4. Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
7.8.7. South Korea
7.8.7.1. Key Country Dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Regulatory Framework
7.8.7.4. South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
7.9. Latin America
7.9.1. Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
7.9.2. Brazil
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
7.9.3. Argentina
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
7.10. MEA
7.10.1. MEA Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.2. South Africa
7.10.2.1. Key Country Dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory Framework
7.10.2.4. South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.3. Saudi Arabia
7.10.3.1. Key Country Dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory Framework
7.10.3.4. Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.4. UAE
7.10.4.1. Key Country Dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory Framework
7.10.4.4. UAE Dengue Testing Market, 2018 - 2030 (USD Million)
7.10.5. Kuwait
7.10.5.1. Key Country Dynamics
7.10.5.2. Competitive Scenario
7.10.5.3. Regulatory Framework
7.10.5.4. Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Strategy Mapping
8.4. Company Market Share Analysis, 2024
8.5. Company Profiles
8.5.1. Thermo Fisher Scientific Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Abbott
8.5.2.1. Overview
8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. F. Hoffmann?La?Roche Ltd.
8.5.3.1. Overview
8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. InBios International, Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. NovaTec Immundiagnostica GmbH
8.5.5.1. Overview
8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Abnova Corporation
8.5.6.1. Overview
8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. PerkinElmer Inc. (Euroimmun AG)
8.5.7.1. Overview
8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Certest Biotec
8.5.8.1. Overview
8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. DiaSorin S.p.A.
8.5.9.1. Overview
8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Quest Diagnostics Incorporated
8.5.10.1. Overview
8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 Global Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 3 Global Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 4 Global Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 5 Global Dengue Testing Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 8 North America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 9 North America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 11 U.S. Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 12 U.S. Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 13 Canada Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 14 Canada Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 15 Canada Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 16 Mexico Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 17 Mexico Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 18 Mexico Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 21 Europe America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 22 Europe America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 23 UK Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 24 UK Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 25 UK Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 26 Germany Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 27 Germany Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 28 Germany Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 29 France Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 30 France Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 31 France Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 32 Italy Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 33 Italy Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 34 Italy Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 35 Spain Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 36 Spain Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 37 Spain Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 38 Denmark Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 39 Denmark Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 40 Denmark Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 41 Sweden Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 42 Sweden Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 43 Sweden Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 44 Norway Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 45 Norway Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 46 Norway Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 51 Japan Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 52 Japan Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 53 Japan Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 54 China Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 55 China Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 56 China Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 57 India Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 58 India Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 59 India Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 60 Australia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 61 Australia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 62 Australia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 63 Thailand Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 64 Thailand Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 65 Thailand Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 66 South Korea Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 67 South Korea Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 68 South Korea Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 69 Latin America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 71 Latin America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 72 Latin America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 73 Brazil Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 74 Brazil Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 75 Brazil Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 76 Argentina Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 77 Argentina Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 78 Argentina Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Dengue Testing Market, by product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 83 South Africa Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 84 South Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 85 South Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 89 UAE Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 90 UAE Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 91 UAE Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 92 Kuwait Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 93 Kuwait Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 Global Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 3 Global Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 4 Global Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 5 Global Dengue Testing Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 8 North America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 9 North America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 11 U.S. Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 12 U.S. Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 13 Canada Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 14 Canada Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 15 Canada Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 16 Mexico Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 17 Mexico Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 18 Mexico Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 21 Europe America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 22 Europe America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 23 UK Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 24 UK Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 25 UK Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 26 Germany Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 27 Germany Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 28 Germany Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 29 France Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 30 France Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 31 France Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 32 Italy Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 33 Italy Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 34 Italy Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 35 Spain Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 36 Spain Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 37 Spain Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 38 Denmark Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 39 Denmark Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 40 Denmark Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 41 Sweden Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 42 Sweden Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 43 Sweden Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 44 Norway Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 45 Norway Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 46 Norway Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 51 Japan Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 52 Japan Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 53 Japan Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 54 China Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 55 China Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 56 China Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 57 India Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 58 India Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 59 India Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 60 Australia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 61 Australia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 62 Australia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 63 Thailand Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 64 Thailand Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 65 Thailand Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 66 South Korea Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 67 South Korea Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 68 South Korea Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 69 Latin America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 71 Latin America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 72 Latin America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 73 Brazil Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 74 Brazil Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 75 Brazil Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 76 Argentina Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 77 Argentina Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 78 Argentina Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Dengue Testing Market, by product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 83 South Africa Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 84 South Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 85 South Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 89 UAE Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 90 UAE Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 91 UAE Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
Table 92 Kuwait Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
Table 93 Kuwait Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Dengue Testing Market segmentation
Fig. 8 Market snapshot, 2024
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Dengue testing market: Product movement analysis
Fig. 15 Dengue testing market: Product outlook and key takeaways
Fig. 16 ELISA-based Tests market estimates and forecast, 2018 - 2030
Fig. 17 Dengue IgG/IgM Detection Kits market estimates and forecast, 2018 - 2030
Fig. 18 RT-PCR Tests market estimates and forecast, 2018 - 2030
Fig. 19 Rapid Diagnostic Tests (RDTs) market estimates and forecast, 2018 - 2030
Fig. 20 NS1 Antigen Detection Kits market estimates and forecast, 2018 - 2030
Fig. 21 Lateral Flow Immunoassay market estimates and forecast, 2018 - 2030
Fig. 22 Dengue testing market: Service Type movement analysis
Fig. 23 Dengue testing market: Service Type outlook and key takeaways
Fig. 24 Centralized Service market estimates and forecast, 2018 - 2030
Fig. 25 POC Service market estimates and forecast, 2018 - 2030
Fig. 26 Dengue testing market: End use movement analysis
Fig. 27 Dengue testing market: End use outlook and key takeaways
Fig. 28 Clinical Labs market estimates and forecast, 2018 - 2030
Fig. 29 Hospitals /Clinics market estimates and forecast, 2018 - 2030
Fig. 30 Home Healthcare market estimates and forecast, 2018 - 2030
Fig. 31 Government Suppliers market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Regional outlook, 2024 & 2030
Fig. 34 Global Dengue Testing Market: Region movement analysis
Fig. 35 North America Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 36 U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 37 Canada Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 38 Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 39 Europe Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 41 UK Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 42 France Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 43 Italy Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 44 Spain Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 45 Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 46 Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 47 Norway Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 49 Japan Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 50 China Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 51 India Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 53 South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 54 Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 57 Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 58 Middle East and Africa Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 59 South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 61 UAE Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Dengue Testing Market segmentation
Fig. 8 Market snapshot, 2024
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Dengue testing market: Product movement analysis
Fig. 15 Dengue testing market: Product outlook and key takeaways
Fig. 16 ELISA-based Tests market estimates and forecast, 2018 - 2030
Fig. 17 Dengue IgG/IgM Detection Kits market estimates and forecast, 2018 - 2030
Fig. 18 RT-PCR Tests market estimates and forecast, 2018 - 2030
Fig. 19 Rapid Diagnostic Tests (RDTs) market estimates and forecast, 2018 - 2030
Fig. 20 NS1 Antigen Detection Kits market estimates and forecast, 2018 - 2030
Fig. 21 Lateral Flow Immunoassay market estimates and forecast, 2018 - 2030
Fig. 22 Dengue testing market: Service Type movement analysis
Fig. 23 Dengue testing market: Service Type outlook and key takeaways
Fig. 24 Centralized Service market estimates and forecast, 2018 - 2030
Fig. 25 POC Service market estimates and forecast, 2018 - 2030
Fig. 26 Dengue testing market: End use movement analysis
Fig. 27 Dengue testing market: End use outlook and key takeaways
Fig. 28 Clinical Labs market estimates and forecast, 2018 - 2030
Fig. 29 Hospitals /Clinics market estimates and forecast, 2018 - 2030
Fig. 30 Home Healthcare market estimates and forecast, 2018 - 2030
Fig. 31 Government Suppliers market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Regional outlook, 2024 & 2030
Fig. 34 Global Dengue Testing Market: Region movement analysis
Fig. 35 North America Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 36 U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 37 Canada Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 38 Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 39 Europe Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 41 UK Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 42 France Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 43 Italy Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 44 Spain Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 45 Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 46 Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 47 Norway Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 49 Japan Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 50 China Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 51 India Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 53 South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 54 Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 57 Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 58 Middle East and Africa Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 59 South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 61 UAE Dengue Testing Market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)
